chloroatranol: major allergen from oak moss absolute [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6426722 |
| CHEBI ID | 144135 |
| SCHEMBL ID | 21333853 |
| MeSH ID | M0468414 |
| Synonym |
|---|
| chloroatranol |
| 3-chloro-2,6-dihydroxy-4-methylbenzaldehyde |
| CHEBI:144135 |
| 57074-21-2 |
| AKOS006227919 |
| DTXSID90423784 |
| benzaldehyde, 3-chloro-2,6-dihydroxy-4-methyl- |
| chloratranol |
| IOTAGSGSURFFDS-UHFFFAOYSA-N |
| SCHEMBL21333853 |
| 3-chloro-2,6-dihydroxy-4-methyl-benzaldehyd |
| D93061 |
| CS-0359796 |
| 3-chloro-2,6-dihydroxy-4-methylbenzaldehyde; chloroatranol; benzaldehyde, 3-chloro-2,6-dihydroxy-4-methyl- |
| AS-77056 |
| mfcd06797952 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Chloroatranol and atranol have been identified as the main allergens in the fragrance material of botanical origin, oak moss absolute. " | ( Content of oak moss allergens atranol and chloroatranol in perfumes and similar products. Bernard, G; Bossi, R; Giménez-Arnau, E; Johansen, JD; Lepoittevin, JP; Menné, T; Rastogi, SC, 2004) | 2.03 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-response curves were estimated and analysed by logistic regression." | ( Comparison of elicitation potential of chloroatranol and atranol--2 allergens in oak moss absolute. Andersen, KE; Bernard, G; Bruze, M; Giménez-Arnau, E; Johansen, JD; Lepoittevin, JP, 2006) | 0.6 |
| Class | Description |
|---|---|
| hydroxybenzaldehyde | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.24) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (23.08%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (76.92%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||